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Type of article: Letter to the Editor 
Title: Mechanisms of neurological injury in COVID -19. 
We read with much interest the article “Neurological Impact of Coronavirus Disease (COVID-
19): Practical Considerations for the Neuroscience Community” by Werner et al. published in 
your esteemed Journal. Authors have described the various neurological details of COVID - 19 
in detail.1 We believe this topic is important and is continuously evolving. We have the 
following comments as an addition to the article. 
 
Symptomatic patients with COVID  -19 can present with mild, moderate, or severe illness. 
Across all studies, patients with severe illness have multi-organ involvement. Patients with 
severe disease are prone to develop acute respiratory distress syndrome (ARDS), acute cardiac 
injury, acute renal failure, acute liver dysfunction.2 While several patterns of central nervous 
system involvement have been reported among these patients, diffuse CNS involvement has been 
reported to be higher.3 
Multiple mechanisms could contribute to the initiaton and progression of CNS injury in COVID 
- 19 patients.  
i] Cytokine storm, defined as dysfunctional, uncontr lled, continuous activation of inflammation 
has been consistently reported across all studies. Thi  exaggerated inflammation has been 
postulated to contribute to ARDS, myocardial injury, renal failure, severity of illness, 
requirement of intensive care unit admission, requirement of mechanical ventilation, and 
mortality. This has been diagnosed with an elevated level of inflammatory markers including C-
reactive protein, leukocytes, pro calcitonin, proBNP, ferritin, interleukins, and various other 
inflammatory markers. While diffuse CNS involvement is noted to be higher among patients 
with severe illness, a temporal association between inflammatory markers and CNS dysfunction 
is not yet shown.4,5 
ii] Autopsy studies on COVID -19 patients have been limited. Direct viral invasion has been 
reported in various organs including lung, liver, and heart. However, no reports have yet 
identified the virus, or viral particles in the brain.6  
Iii] hypoxia induced apoptosis and ischemia, presenting in most patients as multiorgan 
dysfunction.7 
iv] prothrombotic state secondary to endothelial injury, thrombocytopenia, deranged coagulation 
parameters as evident from the raised D-dimer, fibrinogen, prothrombin time.6,8  
v] embolic events secondary to myocardial dysfunction, with increased risk of arrhythmia. This 
has been supported by the presence of several raised cardiac markers including high-sensitivity 
troponins, and D-dimer.6,8,9 
vi] among patients with severe illness multiple other contributors of central nervous system 
dysfunction requiring consideration are a) prolonged requirement of CNS depressing agents 
including benzodiazepines [Diazepam, Midazolam], Opioids [Fentanyl, Morphine], anesthetic 
agent [propofol], and neuromuscular blocking agents to achieve better ventilation goal in patients 
with severe ARDS, b) prolonged ICU stay, c) presence of cardiogenic and septic shock, d)  CNS 
side effects of other medications including corticosteroid, antibiotics etc.6,9-11  
 
Finally, cerebrovascular injury is being commonly reported in patients with COVID-19. Studies 
have shown that patients with severe COVID- 19 had higher cardio-cerebrovascular 
comorbidities including older age, hypertension, diabetes mellitus, hyperlipidemia, heart failure, 
coronary artery disease, and cerebrovascular disease.12,13 A recent study also showed that 
patients with severe COVID -19 had higher cerebrovascular events as compared to patients 
without severe Illness.3 We agree with the authors that future studies will be instrumental in 
clarifying patterns, predictors and outcome of COVID -19 related neurological injury,  
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